Your browser doesn't support javascript.
loading
Non-invasive diagnosis and follow-up of autoimmune hepatitis.
Lemoinne, Sara; Heurgue, Alexandra; Bouzbib, Charlotte; Hanslik, Bertrand; Gournay, Jérôme; Nguyen-Khac, Eric; Bureau, Christophe; de Lédinghen, Victor; Ganne-Carrié, Nathalie; Bourlière, Marc.
Afiliação
  • Lemoinne S; Assistance publique-hopitaux de Paris (AP-HP), Service d'hépatologie, Centre de référence pour les maladies inflammatoires des voies biliaires et les hépatites auto-immunes ( CMR MIVB-H, ERN RARE-LIVER), Hôpital Saint-Antoine, Paris France; Sorbonne Université, INSERM, Centre de Recherche Saint-Anto
  • Heurgue A; Service d'hépato-gastroentérologie et cancérologie digestive, CHU Reims, Reims, France.
  • Bouzbib C; Service d'Hépatologie, Hopital Pitié Salpêtrière, APHP, Paris, France.
  • Hanslik B; Centre Montpelliérain des maladies du foie et de l'appareil digestif, Montpellier, France.
  • Gournay J; Service d'hépato-gastroentérologie, cancérologie digestive et assistance nutritionnelle, CHU Nantes, Nantes, France.
  • Nguyen-Khac E; Service d'hépato-gastroentérologie, CHU Amiens-Picardie, Amiens, France.
  • Bureau C; Service d'hépatologie, Hôpital Rangueil, CHU Toulouse, Toulouse, France.
  • de Lédinghen V; Service d'hépato-gastroentérologie, Hôpital Haut-Lévêque, CHU Bordeaux, pessac & INSERM U1053, Université de Bordeaux, Bordeaux, France.
  • Ganne-Carrié N; Service d'hépatologie, Hôpital Avicenne, APHP, Université Sorbonne Paris Nord, Bobigny & INSERM UMR 1138, Centre de Recherche des Cordeliers, Université de Paris, France.
  • Bourlière M; Service d'hépato-gastroentérologie, Hôpital Saint Joseph & INSERM UMR 1252 IRD SESSTIM Aix Marseille Université, Marseille, France.
Clin Res Hepatol Gastroenterol ; 46(1): 101772, 2022 01.
Article em En | MEDLINE | ID: mdl-34332126
ABSTRACT
Autoimmune hepatitis (AIH) is a liver disease characterised by necrotico-inflammatory lesions of hepatocytes, the presence of specific autoantibodies and response to corticosteroid treatment. AIH must be considered in any patient with acute or chronic liver disease. As there is no pathognomonic sign of AIH, the diagnosis is based on a combination of clinical, biological, immunological and histological findings, after excluding other causes of liver disease. The clinical and biological presentation of AIH is variable and AIH can be associated with an autoimmune biliary disease, primary biliary cholangitis or primary sclerosing cholangitis in an overlap syndrome. For these reasons, diagnosis of AIH can be challenging. Even if liver histology remains essential in the diagnosis of AIH, non-invasive tests can be used at different steps of the management of AIH diagnosis of AIH, notably diagnosis of an overlap syndrome, assessment of severity of AIH, searching for extra-hepatic disease frequently associated to AIH, evaluation of response to therapy, decision of treatment withdrawal. This review aims to provide practical guidelines for the use of non-invasive tests for the diagnosis and the follow-up of AIH.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colangite Esclerosante / Hepatite Autoimune / Cirrose Hepática Biliar Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colangite Esclerosante / Hepatite Autoimune / Cirrose Hepática Biliar Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article